Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Enterprise Value came in at -$329.5 million in Q1 2026, up 21.17% year-on-year from -$271.9 million in Q1 2025, and down 7.13% quarter-over-quarter from -$307.5 million in Q4 2025.
Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026) Analysis & Trends
Prothena Corp Public's Enterprise Value history runs 15 years deep, the most recent figure standing at -$329.5 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 21.17% year-over-year to -$329.5 million in Q1 2026; TTM through Mar 2026 was -$329.5 million, a 21.17% increase from a year earlier, with the FY2025 full-year figure at -$307.5 million, up 34.76% from the prior year.
- Enterprise Value fell to -$329.5 million in Q1 2026 per PRTA's latest filing, from -$307.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$307.5 million in Q4 2025 and bottomed at -$710.4 million in Q4 2022.
- The 5-year median for Enterprise Value is -$519.3 million (2024), against an average of -$515.1 million.
- Across the five-year window, Enterprise Value sank 57.69% in 2022 and surged 36.29% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$710.4 million in 2022, then climbed by 12.7% to -$620.2 million in 2023, then gained by 23.99% to -$471.4 million in 2024, then soared by 34.76% to -$307.5 million in 2025, then retreated by 7.13% to -$329.5 million in 2026.
- Per Business Quant, the three latest PRTA Enterprise Value figures stand at -$329.5 million (Q1 2026), -$307.5 million (Q4 2025), and -$330.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | -329.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -329.46 Mn |
| Dec 31, 2025 | -307.53 Mn |
| Sep 30, 2025 | -330.84 Mn |
| Jun 30, 2025 | -371.40 Mn |
| Mar 31, 2025 | -417.94 Mn |
| Dec 31, 2024 | -471.39 Mn |
| Sep 30, 2024 | -519.26 Mn |
| Jun 30, 2024 | -564.12 Mn |
| Mar 31, 2024 | -547.86 Mn |
| Dec 31, 2023 | -620.18 Mn |
| Sep 30, 2023 | -672.25 Mn |
| Jun 30, 2023 | -660.46 Mn |
| Mar 31, 2023 | -686.18 Mn |
| Dec 31, 2022 | -710.41 Mn |
| Sep 30, 2022 | -495.63 Mn |
| Jun 30, 2022 | -508.80 Mn |
| Mar 31, 2022 | -542.99 Mn |
| Dec 31, 2021 | -579.09 Mn |
| Sep 30, 2021 | -600.10 Mn |
| Jun 30, 2021 | -401.18 Mn |